55
Bambusa Therapeutics, Inc. raises $53.3M under Reg D
Company raise · Raising · Offering $88.9M · Sold $53.3M · BOSTON, MA · filed 2025-02-26
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| Helmut Jeggle | Director |
| Shanshan Xu | Executive Officer, Director, Promoter |
Signed by Isabelle Muldner, Secretary.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.